WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC – Vertex Pharmaceuticals Incorporated Transaction History
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC portfolio value:
$858,000
portfolio value
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.44% | -13 shares | 19K | $289.54 | 2.96K |
| Q2 2022 | share | Increase | +0.78% | 23 shares | 44K | $281.79 | 2.97K |
| Q1 2022 | share | Increase | +2.07% | 60 shares | 160K | $260.97 | 2.95K |
| Q4 2021 | share | Decrease | -0.65% | -19 shares | 107K | $222.45 | 2.89K |
| Q3 2021 | share | Decrease | -0.61% | -18 shares | -63K | $181.39 | 2.91K |
| Q2 2021 | share | Decrease | -4.37% | -134 shares | -67K | $201.63 | 2.93K |
| Q1 2021 | share | Decrease | -3.80% | -121 shares | -95K | $214.89 | 3.06K |
| Q4 2020 | share | Increase | +0.54% | 17 shares | -109K | $236.34 | 3.18K |
| Q3 2020 | share | 0.00% | 0 shares | -58K | $272.12 | 3.16K | |
| Q2 2020 | share | Increase | +3.60% | 110 shares | 192K | $290.31 | 3.16K |
| Q1 2020 | share | Increase | +6.89% | 197 shares | 102K | $237.95 | 3.05K |
| Q4 2019 | share | 0.00% | 0 shares | 141K | $218.95 | 2.86K | |
| Q3 2019 | share | 0.00% | 0 shares | -40K | $169.42 | 2.86K | |
| Q2 2019 | share | 0.00% | 0 shares | -1K | $183.38 | 2.86K | |
| Q1 2019 | share | 0.00% | 0 shares | 52K | $183.95 | 2.86K | |
| Q4 2018 | share | 0.00% | 0 shares | -77K | $165.71 | 2.86K | |
| Q3 2018 | share | 0.00% | 0 shares | 65K | $192.74 | 2.86K | |
| Q2 2018 | share | Increase | +1.63% | 46 shares | 27K | $169.96 | 2.86K |
| Q1 2018 | share | 0.00% | 0 shares | 37K | $162.98 | 2.81K | |
| Q4 2017 | share | Decrease | -18.00% | -618 shares | -100K | $149.86 | 2.81K |
| Q3 2017 | share | Increase | +21.95% | 618 shares | 159K | $152.04 | 3.43K |
| Q2 2017 | share | 0.00% | 0 shares | 55K | $128.87 | 2.81K | |
| Q1 2017 | share | 0.00% | 0 shares | 101K | $109.35 | 2.81K | |
| Q4 2016 | share | 0.00% | 0 shares | -38K | $73.67 | 2.81K | |
| Q3 2016 | share | Decrease | -1.40% | -40 shares | -1K | $87.21 | 2.81K |
| Q2 2016 | share | 0.00% | 0 shares | 19K | $86.02 | 2.85K | |
| Q1 2016 | share | 0.00% | 0 shares | -132K | $79.49 | 2.85K |